Today: 1 July 2026
Lockheed Martin stock price dips as Davos criticism and Greenland tariff threats rattle defense names

Lockheed Martin stock price dips as Davos criticism and Greenland tariff threats rattle defense names

New York, Jan 20, 2026, 3:16 PM EST — Regular session

Shares of Lockheed Martin Corp dropped roughly 1.1% to $576.12 in Tuesday afternoon trading. RTX slipped around 2.1%, Northrop Grumman declined about 1.6%, while General Dynamics dropped close to 2.2%.

The slide follows concerns over new trade tensions sparked by President Donald Trump’s Greenland move, which has led to tariff threats against European allies. EU leaders will meet at an emergency summit in Brussels on Thursday to discuss possible retaliation, including a tariff package targeting 93 billion euros ($108 billion) of U.S. imports. That package could kick in on Feb. 6 once a suspension period ends. Treasury Secretary Scott Bessent called on critics to “calm down the hysteria” and “take a deep breath.” Reuters

On the Davos stage, Bessent singled out major U.S. defense contractors, naming Lockheed and others, accusing them of “letting down the American people” by lagging on government orders. He urged companies to “build more factories and buy back less stock.” (A buyback is when a company repurchases its own shares, often to boost earnings per share.) Business Insider

Policy tensions have left investors wary, despite steady demand for weapons, particularly following Monday’s U.S. market holiday. “Common alliances, which we thought could weather all sorts of storms, are shifting,” said Wasif Latif, chief investment officer at Sarmaya Partners. Amelie Derambure of Amundi called the markets “precautionary mode.” Reuters

Lockheed supplies fighter jets, missiles, and space systems to the Pentagon and U.S. allies, making its stock sensitive to any signs of increased scrutiny, delayed shipments, or changes in export policies. Investors also see it as a reliable cash machine when interest rates fluctuate or risk appetite shifts.

Traders now face straightforward, immediate concerns: will production stay on pace, will supply chains hold up, and does management sound confident about turning signed orders into delivered hardware? They’ll also seek an updated look at the backlog—the stockpile of contracted work still pending—and how fast it’s translating into revenue.

The downside risk is clear. Should the tariff dispute escalate and allies strike back, the fallout could extend beyond just consumer goods. The longer the standoff lasts, the more strain it puts on defense procurement practices and international supply chains. Meanwhile, Washington’s pressure might escalate, leading to stricter contract conditions that limit contractors’ ability to manage inevitable shortfalls.

Lockheed plans to release its fourth-quarter and full-year 2025 earnings before the market opens on Jan. 29. The company will hold a conference call at 8:30 a.m. ET, featuring CEO Jim Taiclet and CFO Evan Scott, it said.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Morgan Stanley Lifts UnitedHealth (UNH) Target to $468 Before Q2 Report
    July 1, 2026, 10:26 AM EDT. Morgan Stanley bumped its price target on UnitedHealth (UNH) to $468 from $453 with Q2 results due July 16, implying about 13% upside. Analyst Erin Wright cited "incrementally reassuring" utilization data and a $1.5 billion AI investment as positives. Bernstein SocGen stuck with an Outperform and a $492 target, calling for Q2 adjusted EPS of $5.22, above consensus. Shares are up 24% for the year, trading close to a 52-week high. The bullish case centers on Medicare Advantage margins and leaving unprofitable contracts. On the other side, TD Cowen cut its target to $197, pointing to growth and regulatory pressures but kept a Buy rating. UnitedHealth's full-year adjusted EPS guidance remains above $18.25, supporting the upbeat view into earnings.
UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals
Previous Story

UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals

Accenture stock price rises as Palantir-backed “sovereign AI” data-center deal grabs focus
Next Story

Accenture stock price rises as Palantir-backed “sovereign AI” data-center deal grabs focus

Go toTop